Alzey Pharmaceuticals Private Limited, a active private limited company, was established on 23 September 2020 in Barwala, Haryana, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U51397HR2020PTC089594. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹3.50 M and a paid-up capital of ₹3.50 M.
Formerly known as Alzey Pharmaceutical Private Limited. Its leadership includes Sumeet Chaudhry (Additional Director), Puneet Chaudhry (Director), Preeti Chaudhry (Director). Past directors included Neeraj Madan, Swati Bhalla, Prabha Chowdhary. It holds ₹1.00 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No 202, Industrial Area, Phase-1 Hsiidc, Industrial Estate, Alipur, Barwala, Haryana, 134118.
U51397HR2020PTC089594
089594
23 September 2020
₹3.50 M
₹3.50 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Alzey Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sumeet Chaudhry | Additional Director | 18 Jan 2021 | Current |
| Puneet Chaudhry | Director | 09 Apr 2022 | Current |
| Preeti Chaudhry | Director | 09 Apr 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 09 Apr 2022 | Past |
| Pramod Abcsdd | Director | 26 Apr 2022 | Past |
| Pramod Abcsdd | Director | 09 Apr 2022 | Past |
| Pramod Abcsdd | Director | 09 Apr 2022 | Past |
| Pramod Abcsdd | Director | 10 Jan 2024 | Past |
| Pramod Abcsdd | Additional Director | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Alzey Pharmaceuticals Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 30% increase. The company also saw a substantial improvement in profitability, with a 21.2% increase in profit. The company's net worth Soared by an impressive increase of 36.21%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Alzey Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹10,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Feb 2021 | Others | ₹1.00 Cr | Open |
Explore comprehensive loan charge details -
Alzey Pharmaceuticals has a workforce of 0 employees as of Aug 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Alzey Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alzey Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Alzey Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Alzey Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
The activity Puneet Chaudhry was appointed as a Director was appointed as a Director on 09 Apr 2022 & has been associated with this company since 3 years 8 months . was completed.
Progress on Preeti Chaudhry was appointed as a Director was appointed as a Director on 09 Apr 2022 & has been associated with this company since 3 years 8 months . was documented.
Progress on A charge with Others amounted to Rs. 10.00 M with Charge ID 100424070 was registered on 06 Feb 2021. was documented.
The activity Sumeet Chaudhry was appointed as a Additional Director was appointed as a Additional Director on 18 Jan 2021 & has been associated with this company since 4 years 11 months . was completed.
The CIN of Alzey Pharmaceuticals Private Limited is U51397HR2020PTC089594.
Alzey Pharmaceuticals Private Limited is headquartered at Plot No 202, Industrial Area, Phase-1 Hsiidc, Industrial Estate, Alipur, Barwala, Haryana, 134118.
Alzey Pharmaceuticals Private Limited was incorporated on 23 September 2020.
The current directors of Alzey Pharmaceuticals Private Limited are
The primary industry of Alzey Pharmaceuticals Private Limited is Trade.
Alzey Pharmaceuticals Private Limited is unlisted.
The authorized capital of Alzey Pharmaceuticals Private Limited is ₹3.50 M, and the paid-up capital is ₹3.50 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX